1. Strong network with our partnering companies

  Threshold Pharmaceuticals is a public company in the U.S., (IPO in year 2005), currently conducting Phase III clinical trial of glufosfamide. We partner with Threshold and its Phase 1 clinical trial has been ongoing in Japan since January 2007.

2. Experts in drug development handle the whole process starting from planning of clinical development strategy to actual development tasks

  Our staffs have extensive clinical development background from major domestic pharmaceutical companies. They take care of strategic planning and actual development tasks with the flexibility and fast footwork of a venture company.

3. Science, Technology, and Finance

  Experts in various field including Pharmacogenomics, bioinformatics, and finance, are providing comprehensive support to the drug development project.